Additional early-stage research and drug discovery news in brief, from: Allegro, Nuvectis, Traws.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Arbutus, Ipsen, Genevant, Marengo, Mitocarex, Nkgen, Oqory, Scisparc, Vincerx, Vivasor.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, Boston Scientific, Cleerly, Bunkerhill Health, Deepqure, Discure Technologies, Levee Medical, Lunit, Microlight3D, Optellum, Parse Biosciences, Spinal Stabilization Technologies, Volpara.

Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Biond Biologics, Carsgen, Eisai, Epimab, Hansoh, Holling Bio-Pharma, Infex, Idorsia, Ligand, Medigene, Nxera, Sanofi, Sciclone, Silence, Venus Remedies, Ucarsgen.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Biond, Bridgebio, Eisai, GQ Bio Therapeutics, Helix Acquisition, Holling Bio-Pharma, Mustang Bio, Neuren, Nxera, Pacira, Sanofi, Sciclone, Theras.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biomérieux, Namsa, Qiagen, Sterotaxis, Wuxi Apptec.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biosymetrics, Epimab, Eli Lilly, Hansoh, Ligand, Medigene, Renovaro, Schrödinger, Silence, Verve, Vertex, Zerve.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Adagio Medical, Devicor Medical, Imaginesoftware, Konica-Minolta, Life Imaging, Lucid, Mammotome, Medimira Merck, Milliporesigma, Neuralcure, Nexalin, Nucleus Genomics, Rapid Micro Biosystems, Shanghai Chartwell Medical, Sirius Medical, Ubie, Venus Concept, Work Medical.

Additional early-stage research and drug discovery news in brief, from: Cognition Therapeutics, Inventiva.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Allogene, Enodia, Eli Lilly, Foresight, Idorsia, Nxera, Pfizer, Viatris.